Form 4: Orchestra BioMed Holdings Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David P. Hochman, a director and officer of Orchestra BioMed Holdings, Inc., disposed of shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 7, 2025, David P. Hochman, a director and officer of Orchestra BioMed Holdings, Inc., disposed of 80,080 shares of common stock to satisfy tax withholding obligations.
- The shares were withheld by the issuer at a price of $4.23 per share.
- Following the transaction, Hochman directly owns 499,418 shares of Orchestra BioMed Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading for tax purposes, and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency when company insiders trade their own company's stock. They do not necessarily indicate a change in the company's prospects.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the sale of shares, but it is primarily related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of transaction: disposal of shares to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.